Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
ODT
Odyssey Therapeutics
ODTX
Return on equity
Return on equity at other companies
Berkshire Hathaway
BRK.A
10.5%
-2.7pp
Synopsys
SNPS
3.8%
-21.5pp
Northern Trust
NTRS
14.5%
-3.2pp
Nucor
NUE
11.2%
+4.7pp
Dycom Industries
DY
19.7%
-0.1pp
Barnes Group
B
-3%
-4.9pp
Other financials
Income statement
See full
Revenue
-
-100%
Operating income
-$55.5M
-32.3%
Net income
-$52.8M
-28.0%
EPS (diluted)
-$1.74
+94.1%
Balance sheet
See full
Cash & equivalents
$82.0M
-49.7%
Total debt
$24.8M
+8,175%
Total equity
$421.2M
+197%
Total assets
$483.9M
—
Cash flow
See full
Operating cash flow
-$34.5M
-0.7%
CapEx
$186.0K
+541%
Free cash flow
-$34.7M
-1.2%
Valuation
See full
Market cap
$1B
+27.8%
Enterprise value
$946.17M
—
P/S
348.8×
—
Profitability
See full
Operating margin
-6,129%
—
Net margin
-5,934%
—
FCF margin
-5,203.9%
—
Returns & leverage
See full
Debt / equity
0.1×
—
Current ratio
11.4×
—
Watchlist
Screener
Filings
Earnings
Charts